1. | | No longer recruiting | 506U78 in Treating Patients With Refractory Hematologic Cancer Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia |
2. | | No longer recruiting | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Conditions: stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; cardiac toxicity; stage I childhood Hodgkin's disease; ... |
3. | | No longer recruiting | Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia Conditions: recurrent childhood acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia |
4. | | No longer recruiting | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors Conditions: Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors |
5. | | No longer recruiting | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease Conditions: stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; childhood lymphocyte predominant Hodgkin's disease; ... |
6. | | No longer recruiting | Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia Conditions: L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia |
7. | | No longer recruiting | Combination Chemotherapy in Treating Children With Lymphoma Conditions: stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma |
8. | | No longer recruiting | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia Conditions: L1 childhood acute lymphocytic leukemia; L2 childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia |
9. | | No longer recruiting | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia Conditions: Quality of Life; recurrent childhood acute lymphoblastic leukemia |
10. | | No longer recruiting | Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy Condition: unspecified childhood solid tumor, protocol specific |
11. | | Completed | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Conditions: recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; Previously Treated Myelodysplastic Syndrome |
12. | | Completed | Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor Conditions: metastatic tumors of the Ewing's family; Neutropenia |
13. | | No longer recruiting | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma Conditions: cardiac toxicity; localized osteosarcoma |
14. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma Condition: disseminated neuroblastoma |
15. | | No longer recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor Conditions: untreated childhood supratentorial primitive neuroectodermal and pineal tumors; untreated childhood medulloblastoma |
16. | | Completed | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia Condition: untreated childhood acute lymphoblastic leukemia |
17. | | No longer recruiting | Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Conditions: Previously Treated Myelodysplastic Syndrome; untreated childhood acute myeloid leukemia; secondary myelodysplastic syndrome; ... |
18. | | No longer recruiting | Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia Condition: recurrent childhood acute lymphoblastic leukemia |
19. | | No longer recruiting | Docetaxel in Treating Children With Recurrent Solid Tumors Conditions: recurrent childhood brain stem glioma; recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood ependymoma; ... |
20. | | No longer recruiting | Fenretinide in Treating Children With Solid Tumors Conditions: unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma |
21. | | Completed | Gemcitabine in Treating Children With Refractory Solid Tumors Condition: unspecified childhood solid tumor, protocol specific |
22. | | Completed | Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma Conditions: long-term effects secondary to cancer therapy in children; previously treated childhood rhabdomyosarcoma; Quality of Life |
23. | | No longer recruiting | Quality of Life in Children Treated for Cancer Conditions: Leukemia; Lymphoma |
24. | | No longer recruiting | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma Condition: untreated childhood medulloblastoma |
25. | | No longer recruiting | Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors Conditions: disseminated neuroblastoma; untreated childhood supratentorial primitive neuroectodermal and pineal tumors; regional neuroblastoma; ... |
26. | | Completed | Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Condition: desmoid tumor |